Citations per year, relative to Eernisse Jg Eernisse Jg (= 1×)
peers
Barbara Nowicki
Countries citing papers authored by Eernisse Jg
Since
Specialization
Citations
This map shows the geographic impact of Eernisse Jg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eernisse Jg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eernisse Jg more than expected).
This network shows the impact of papers produced by Eernisse Jg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eernisse Jg. The network helps show where Eernisse Jg may publish in the future.
Co-authorship network of co-authors of Eernisse Jg
This figure shows the co-authorship network connecting the top 25 collaborators of Eernisse Jg.
A scholar is included among the top collaborators of Eernisse Jg based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Eernisse Jg. Eernisse Jg is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
16 of 16 papers shown
1.
Jj, van Rood, et al.. (1984). Blood component therapy in bone marrow transplantation.. PubMed. 21(2). 141–55.21 indexed citations
2.
Jg, Eernisse & Anneke Brand. (1981). Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components.. PubMed. 9(1). 77–83.190 indexed citations
3.
Claas, F.H.J., et al.. (1981). Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension.. PubMed. 9(1). 84–9.174 indexed citations
4.
Brand, A, et al.. (1979). Platelet supportive care: immunological and clinical aspects.. PubMed. 22(4). 133–7.1 indexed citations
5.
Jj, van Rood, et al.. (1978). The importance of non-HLA systems and the feasibility of the use of unrelated donors in bone marrow transplantation.. Transplantation Proceedings. 10(1). 47–51.9 indexed citations
6.
Willemze, R., et al.. (1978). Bone marrow transplantation and (or) immunosuppression with antithymocyte globulin in the treatment of aplastic anemia. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 122(10). 326–332.1 indexed citations
7.
Jg, Eernisse, et al.. (1977). Prevention of bleeding tendency after open-heart surgery for Tetralogy of Fallot.. PubMed. 11(2). 105–9.3 indexed citations
8.
Willemze, Roel, et al.. (1977). [Treatment of acute myelogenous leukemia in adults; an account of the years 1968 to 1975].. PubMed. 121(46). 1843–7.1 indexed citations
Willemze, Roel, et al.. (1975). Treatment of acute myelogenous leukaemia in adults. A retrospective study of 70 patients (1968-1973).. PubMed. 18(1). 17–28.1 indexed citations
Jj, van Rood, et al.. (1974). Typing for the MLC determinants and its possible impact on Europdonor.. PubMed. 6(4). 411–5.2 indexed citations
13.
Speck, B, et al.. (1971). Clinical experience with bone marrow transplantation: failure and success.. PubMed. 3(1). 409–13.13 indexed citations
14.
Meyer, Kellie, et al.. (1967). Treatment of haemophilia A with purified factor 8 obtained from human plasma by cryoprecipitation.. PubMed. 10(2). 49–60.8 indexed citations
15.
Jg, Eernisse, et al.. (1965). TREATMENT OF THROMBOCYTOPENIC PATIENTS WITH REPEATED PLATELET TRANSFUSIONS.. PubMed. 31. 139–45.12 indexed citations
16.
Jg, Eernisse, et al.. (1959). [Antigens against leukocytes in the serum of pregnant women].. PubMed. 103. 1928–31.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.